Behind the Strategy: An Expert’s Perspective
As we enter 2025, the MedTech industry is poised for significant transformation. Two key areas expected to drive growth are robotic surgery and artificial intelligence (AI), which are garnering increasing attention from investors, clinicians, and innovators. However, while these technologies hold immense promise, a critical challenge remains: the absence of separate reimbursement pathways, such as new codes or distinct payment categories. Instead, these innovations must navigate existing reimbursement frameworks, making market access and evidence generation essential for their adoption. Demonstrating their value through proof, rather than a mere proposition, is paramount. Let’s examine these trends and explore the reimbursement and market access insights shaping their trajectory in 2025 and beyond.